What did @socalurologyinstitute actually say?
The creator, presenting as a urologist, made three core claims: that roughly 25% of men on testosterone develop oily skin or acne, that TRT-related breakouts tend to appear on the back rather than the face, and that doxycycline is "the answer" for managing it. He gave a rough dosing framework: once daily for mild acne, twice daily for severe, stop when it clears, restart if it returns. He framed this as the same approach used for teenage acne, which is at least partially accurate in terms of the drug class.
To his credit, he acknowledged that most patients do not develop significant acne on TRT, which is a more measured statement than you usually hear in TRT content. He also did not claim doxycycline is the only option or that it works without fail. Those are reasonable qualifications. The problem is the overall framing: "doxycycline is the answer" is a significant oversimplification for a condition that has multiple drivers and multiple treatment pathways.
Does the science back this up?
Partially. The acne-androgen link is real and well-documented, but the 25% figure is loosely sourced and the doxycycline-first approach skips several steps most dermatologists would take.
Exogenous testosterone raises dihydrotestosterone (DHT) and increases sebaceous gland activity, which is the established mechanism behind androgen-driven acne. A 2021 review by Gallo et al. in the Journal of the American Academy of Dermatology confirmed that androgen excess, including from exogenous sources, is a recognized trigger for acne vulgaris. The 25% prevalence figure the creator cites is plausible but not pinned to a specific study in the video, and published estimates vary widely depending on dose, formulation, and whether DHT-elevating compounds like gels versus injections are used.
Doxycycline does work for inflammatory acne. It inhibits matrix metalloproteinases and has anti-inflammatory properties beyond its antibiotic activity (Skidmore et al., 2003, Archives of Dermatology). But dermatological guidelines from the American Academy of Dermatology recommend doxycycline as part of a broader regimen, typically combined with topical retinoids or benzoyl peroxide, not as a standalone cycling solution. Using oral antibiotics intermittently without adjunct therapy is also associated with antibiotic resistance concerns, which the creator did not mention.
What did they get wrong (or right)?
The back-versus-face observation is genuinely interesting and not wrong, though the explanation is incomplete. Adult males on androgens tend to develop truncal acne more than facial acne, likely because the back and chest have a higher density of androgen-sensitive sebaceous follicles. That part checks out clinically.
What's missing is the role of formulation and hematocrit. Testosterone gels tend to produce higher DHT conversion than injections, making gel users more acne-prone. Pellet users can see supraphysiologic peaks that drive skin issues more aggressively. None of this was mentioned, and it matters because the management approach should differ based on root cause.
The bigger problem is the stop-start antibiotic framework. The creator essentially describes using doxycycline like an on-demand rescue medication. Dermatologists and infectious disease guidelines specifically caution against this because intermittent antibiotic use is one of the primary drivers of Cutibacterium acnes resistance (Thiboutot et al., 2009, Journal of the American Academy of Dermatology). Cyclic, symptom-driven dosing without a topical antibacterial partner is not standard of care.
He also never mentioned topical options, retinoids, dose adjustment of testosterone, or switching formulations as potential first-line interventions before reaching for systemic antibiotics. Those are significant omissions.
What should you actually know?
If you are on TRT and developing acne, the first conversation should be with a dermatologist or your prescribing clinician, not a 60-second video. Here is what the evidence actually supports as a management sequence.
- First, check whether your TRT dose or formulation might be the driver. High-normal or supraphysiologic testosterone levels push DHT conversion up. A dose adjustment or switch from gel to injection (or vice versa) sometimes resolves acne without any medication.
- Topical retinoids (tretinoin) and benzoyl peroxide are first-line for mild to moderate acne in adults, according to AAD guidelines. Jumping to oral doxycycline before trying topical therapy is not the recommended sequence.
- If oral antibiotics are appropriate, they should be used with a topical antimicrobial agent to reduce resistance risk. The AAD advises limiting oral antibiotic courses to three to four months where possible.
- Isotretinoin is reserved for severe, scarring, or antibiotic-resistant cases. It is not mentioned in the video but is a real option for men on TRT with persistent cystic acne.
- Acne on TRT is not inevitable. The creator is right that most patients do not experience significant skin changes. Genetics, baseline sebum production, and formulation matter enormously.